| 000 | 02628nam a22003257a 4500 | ||
|---|---|---|---|
| 008 | 210607s20202020 xxu||||| |||| 00| 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | _a10.1093/jnci/djaa177 [doi] | ||
| 024 | _a5976921 [pii] | ||
| 024 | _aPMC7717327 [pmc] | ||
| 040 | _aOvid MEDLINE(R) | ||
| 099 | _a33179744 | ||
| 245 | _aCardiovascular care of the oncology patient during COVID-19: An expert consensus document from the ACC Cardio-Oncology and Imaging Councils. | ||
| 251 | _aJournal of the National Cancer Institute. 2020 Nov 12 | ||
| 252 | _aJ Natl Cancer Inst. 2020 Nov 12 | ||
| 253 | _aJournal of the National Cancer Institute | ||
| 260 | _c2020 | ||
| 260 | _fFY2021 | ||
| 265 | _saheadofprint | ||
| 266 | _d2020-12-31 | ||
| 520 | _aIn response to the coronavirus disease 2019 (COVID-19) pandemic, The Cardio-Oncology and Imaging Councils of the American College of Cardiology offers recommendations to clinicians regarding the cardiovascular care of cardio-oncology patients in this expert consensus statement. Cardio-oncology patients-individuals with an active or prior cancer history, and with or at risk of cardiovascular disease-are a rapidly growing population, who are both at increased risk of infection by COVID-19 and experiencing severe and/or lethal complications. Recommendations for optimizing screening and monitoring visits to detect cardiac dysfunction are discussed. In addition, judicious use of multimodality imaging and biomarkers are proposed to identify myocardial, valvular, vascular, pericardial involvement in cancer patients. The difficulties of diagnosing the etiology of cardiovascular complications in patients with cancer and COVID-19 are outlined, along with weighing the advantages against risks of exposure, with the modification of existing cardiovascular treatments and cardiotoxicity surveillance in patients with cancer during the COVID-19 pandemic. Copyright (c) The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: [email protected]. | ||
| 546 | _aEnglish | ||
| 650 | _aIN PROCESS -- NOT YET INDEXED | ||
| 651 | _aMedStar Heart & Vascular Institute | ||
| 657 | _aJournal Article | ||
| 700 | _aBarac, Ana | ||
| 790 | _aBaldassarre LA, Barac A, Blaes AH, Bucciarelli-Ducci C, Cheng RK, DeCara JM, Dent S, Deswal A, Ellahham S, Ismail-Khan R, Ky B, Leja MJ, Lenneman C, Liu JE, Rudski LG, Scherrer-Crosbie M, Strom JB, Thavendiranathan P, Villarraga HR, Yang EH, Zaha VG | ||
| 856 |
_uhttps://dx.doi.org/10.1093/jnci/djaa177 _zhttps://dx.doi.org/10.1093/jnci/djaa177 |
||
| 942 |
_cART _dArticle |
||
| 999 |
_c5952 _d5952 |
||